This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.82% per year. These returns cover a period from January 1, 1988 through October 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
autonomous-vehicles: Archive
Should You Buy Lakefront Biotherapeutics - Sponsored ADR (LKFT) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
LKFTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla vs. BYD: Which EV Giant Is Better Charged Right Now?
by Rimmi Singhi
TSLA's improving EV demand, margins and Robotaxi progress give it an edge over BYDDY, which faces domestic sales weakness, rising inventory and trade hurdles.
TSLANegative Net Change BYDDYNegative Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles tech-stocks
PDS Biotechnology (PDSB) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PDSBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Rivian Post-Q3 Analysis: 3 Reasons Why the Stock is a Buy Now
by Rimmi Singhi
Rivian's Q3 earnings beat, record deliveries, R2 SUV momentum, falling unit costs and autonomy push strengthen its growth outlook despite heavy cash burn.
RIVNNegative Net Change TSLANegative Net Change LCIDPositive Net Change
autonomous-vehicles electric-vehicles
Should You Buy GrafTech International (EAF) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EAFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla vs. Ford: Which Stock Has an Edge After Q3 Earnings?
by Rimmi Singhi
TSLA looks better positioned after Q3 earnings, backed by improving vehicle demand, margins and robotaxi progress, while F faces rising costs and EV losses.
FNegative Net Change TSLANegative Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles tech-stocks
Is Tesla's Narrative Shifting? Why the Stock Deserves a Second Look
by Rimmi Singhi
TSLA stock rose 9.5% in the last two trading sessions. Rising EV demand, improving margins and AI progress signal a turnaround. Is the stock worth buying now?
TSLANegative Net Change SPCXNegative Net Change
aerospace artificial-intelligence autonomous-vehicles communications electric-vehicles tech-stocks
Rivian Pre-Q3 Analysis: Is it Worth Buying the Stock Now?
by Rimmi Singhi
RIVN's surging R2 deliveries, expanding software revenues and strong partner funding support its long-term outlook despite margin pressures and cash burn.
RIVNNegative Net Change TSLANegative Net Change LCIDPositive Net Change
autonomous-vehicles electric-vehicles
Ouster Q3 Earnings on Deck: Buy, Hold or Sell OUST Stock Now?
by Rimmi Singhi
Ouster's Q3 earnings loom as Rev8 demand accelerates and smart infrastructure expands, but premium valuation and persistent losses warrant caution.
OUSTNegative Net Change AEVANegative Net Change HSAINegative Net Change
artificial-intelligence autonomous-vehicles tech-stocks
Marriott International (MAR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MARPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines